Aadi Bioscience Company Top Insiders
AADI Stock | USD 1.78 0.06 3.26% |
Aadi Bioscience's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Aadi Bioscience suggests that almost all insiders are panicking. Aadi Bioscience employs about 89 people. The company is managed by 9 executives with a total tenure of roughly 208 years, averaging almost 23.0 years of service per executive, having 9.89 employees per reported executive.
Aadi Bioscience's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-04-01 | Neil Desai | Disposed 17772 @ 2.31 | View | ||
2024-03-04 | Neil Desai | Disposed 14964 @ 2.1 | View | ||
2024-03-01 | Neil Desai | Disposed 27036 @ 1.97 | View | ||
2024-02-01 | Neil Desai | Disposed 42000 @ 1.74 | View | ||
2024-01-02 | Neil Desai | Disposed 42000 @ 2.06 | View | ||
2023-12-06 | Neil Desai | Disposed 7037 @ 4.82 | View | ||
2023-12-04 | Neil Desai | Disposed 10876 @ 5.15 | View | ||
2023-12-01 | Neil Desai | Disposed 8347 @ 5.14 | View | ||
2023-11-01 | Neil Desai | Disposed 10338 @ 4.32 | View | ||
2023-10-02 | Neil Desai | Disposed 25569 @ 4.37 | View | ||
2023-09-05 | Neil Desai | Disposed 21000 @ 5.63 | View | ||
2023-09-01 | Neil Desai | Disposed 13889 @ 5.97 | View | ||
2023-08-01 | Neil Desai | Disposed 22710 @ 5.22 | View | ||
2023-07-05 | Neil Desai | Disposed 16171 @ 6.55 | View | ||
2023-07-03 | Neil Desai | Disposed 10000 @ 6.64 | View | ||
2023-06-05 | Neil Desai | Disposed 17315 @ 8.11 | View | ||
2023-06-01 | Neil Desai | Disposed 4982 @ 7.92 | View | ||
2023-05-03 | Neil Desai | Disposed 7695 @ 7.68 | View | ||
2023-05-01 | Neil Desai | Disposed 24479 @ 7.8 | View |
Monitoring Aadi Bioscience's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Aadi |
Aadi Bioscience Management Team Effectiveness
The company has return on total asset (ROA) of (0.284) % which means that it has lost $0.284 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.499) %, meaning that it created substantial loss on money invested by shareholders. Aadi Bioscience's management efficiency ratios could be used to measure how well Aadi Bioscience manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.52. The Aadi Bioscience's current Return On Capital Employed is estimated to increase to -0.64. As of now, Aadi Bioscience's Other Current Assets are increasing as compared to previous years. The Aadi Bioscience's current Non Current Assets Total is estimated to increase to about 8.2 M, while Intangible Assets are projected to decrease to under 3 M.The Aadi Bioscience's current Common Stock Shares Outstanding is estimated to increase to about 28.3 M, while Net Loss is projected to decrease to (57.2 M).
Aadi Bioscience Workforce Comparison
Aadi Bioscience is rated below average in number of employees category among related companies. The total workforce of Health Care industry is presently estimated at about 3,817. Aadi Bioscience holds roughly 89.0 in number of employees claiming about 2.33% of equities under Health Care industry.
Aadi Bioscience Profit Margins
The company has Profit Margin (PM) of (2.7) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.8) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.8.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.97 | 0.8847 |
|
|
Aadi Bioscience Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aadi Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aadi Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Aadi Bioscience insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Delaney Brendan few days ago Acquisition by Delaney Brendan of 260000 shares of Aadi Bioscience at 29.09 subject to Rule 16b-3 | ||
Delaney Brendan over a week ago Acquisition by Delaney Brendan of 61000 shares of Aadi Bioscience at 17.24 subject to Rule 16b-3 | ||
Neil Desai over three weeks ago Disposition of 22228 shares by Neil Desai of Aadi Bioscience at 2.2275 subject to Rule 16b-3 | ||
Maroun Richard E over a month ago Disposition of 15860 shares by Maroun Richard E of Aadi Bioscience at 2.2 subject to Rule 16b-3 | ||
Maroun Richard E over six months ago Acquisition by Maroun Richard E of 28255 shares of Aadi Bioscience subject to Rule 16b-3 | ||
Satter Muneer A over a year ago Purchase by Satter Muneer A of 20000 shares of Aadi Bioscience |
Aadi Bioscience Notable Stakeholders
An Aadi Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Aadi Bioscience often face trade-offs trying to please all of them. Aadi Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Aadi Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David Lennon | CEO President | Profile | |
Scott CPA | Treasurer, CFO | Profile | |
Neil Desai | President, Founder | Profile | |
Raymond Steitz | Senior Officer | Profile | |
Bryan Ball | Chief Operations | Profile | |
Marcy Graham | SVP Communications | Profile | |
Stephen JD | Senior Counsel | Profile | |
Brendan MBA | Chief Officer | Profile | |
MD FACP | Chief Officer | Profile |
About Aadi Bioscience Management Performance
The success or failure of an entity such as Aadi Bioscience often depends on how effective the management is. Aadi Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Aadi management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Aadi management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.50) | (0.52) | |
Return On Capital Employed | (0.68) | (0.64) | |
Return On Assets | (0.50) | (0.52) | |
Return On Equity | (0.63) | (0.66) |
The data published in Aadi Bioscience's official financial statements usually reflect Aadi Bioscience's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Aadi Bioscience. For example, before you start analyzing numbers published by Aadi accountants, it's critical to develop an understanding of what Aadi Bioscience's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Aadi Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aadi Bioscience's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Aadi Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aadi Bioscience. Please utilize our Beneish M Score to check the likelihood of Aadi Bioscience's management manipulating its earnings.
Aadi Bioscience Workforce Analysis
Traditionally, organizations such as Aadi Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Aadi Bioscience within its industry.Aadi Bioscience Manpower Efficiency
Return on Aadi Bioscience Manpower
Revenue Per Employee | 273.6K | |
Revenue Per Executive | 2.7M | |
Net Loss Per Employee | 738.9K | |
Net Loss Per Executive | 7.3M | |
Working Capital Per Employee | 1.1M | |
Working Capital Per Executive | 10.9M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.Note that the Aadi Bioscience information on this page should be used as a complementary analysis to other Aadi Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Aadi Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.44) | Revenue Per Share 0.905 | Quarterly Revenue Growth 0.21 | Return On Assets (0.28) | Return On Equity (0.50) |
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.